29 Sept 2026, 16:10
Securities Administration—
IVXINVION LIMITED
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 16:09
Capital Raising—
26 Aug 2026, 17:54
Company Administration—
26 Aug 2026, 17:52
Financial ResultsMS
20 Aug 2026, 14:22
Director Interests—
20 Aug 2026, 14:21
Director Interests—
19 Aug 2026, 09:21
Company Administration—
31 July 2026, 13:03
Quarterly ReportsMS
22 June 2026, 10:55
Securities Administration—
22 June 2026, 10:52
Securities Administration—
22 June 2026, 09:24
Company Administration—
19 June 2026, 10:48
Director Interests—
16 June 2026, 16:14
Securities Administration—
12 June 2026, 15:03
Securities Administration—
12 June 2026, 15:01
Securities Administration—
12 June 2026, 14:54
Securities Administration—
12 June 2026, 14:45
Securities Administration—
29 May 2026, 17:10
Meetings & Governance—
19 May 2026, 09:21
Company UpdateMS
11 May 2026, 16:25
Director Interests—
1 May 2026, 14:40
Securities Administration—
30 Apr 2026, 11:40
Quarterly ReportsMS
28 Apr 2026, 10:54
Presentations—
22 Apr 2026, 08:51
Presentations—
21 Apr 2026, 09:46
Company UpdateMS
20 Apr 2026, 12:19
Company Administration—
20 Apr 2026, 12:17
Director Interests—
8 Apr 2026, 11:04
Substantial Holders—
23 Mar 2026, 11:09
Securities Administration—
23 Mar 2026, 11:06
Securities Administration—
23 Mar 2026, 11:06
Securities Administration—
23 Mar 2026, 11:04
Securities Administration—
18 Mar 2026, 16:48
Securities Administration—
12 Mar 2026, 11:22
Securities Administration—
5 Mar 2026, 12:48
Securities Administration—
5 Mar 2026, 12:43
Securities Administration—
5 Mar 2026, 09:48
Securities Administration—
5 Mar 2026, 09:39
Securities Administration—
27 Feb 2026, 09:32
Financial ResultsMS
19 Feb 2026, 09:00
Presentations—
19 Feb 2026, 08:52
Securities Administration—
30 Jan 2026, 18:18
Quarterly ReportsMS
30 Jan 2026, 18:15
Securities Administration—
30 Jan 2026, 18:14
Securities Administration—
30 Jan 2026, 18:14
Securities AdministrationMS
29 Jan 2026, 10:00
Trading Halt / SuspensionMS
29 Jan 2026, 09:44
Trading Halt / SuspensionMS
13 Jan 2026, 11:08
Securities Administration—
23 Dec 2025, 09:37
Company UpdateMS
3 Dec 2025, 08:43
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 Sept 2026, 16:10 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 29 Sept 2026, 16:09 | Director Loans | Capital Raising | — | 03022 | |
| 26 Aug 2026, 17:54 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 17:52 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 20 Aug 2026, 14:22 | Initial Director's Interest Notice - Paul FIeld | Director Interests | — | 02008 | |
| 20 Aug 2026, 14:21 | Final Director's Interest Notice - Alistair Bennallack | Director Interests | — | 02010 | |
| 19 Aug 2026, 09:21 | IVX Credentialed International Biotech Leader Joins Board | Company Administration | — | 12001 | |
| 31 July 2026, 13:03 | Appendix 4C and Quarterly Activities Report - June 2026 | Quarterly Reports | MS | 19004, 19009 | |
| 22 June 2026, 10:55 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 22 June 2026, 10:52 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 22 June 2026, 09:24 | Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor | Company Administration | — | 12008 | |
| 19 June 2026, 10:48 | Change of Directors' Interest Notices x 3 | Director Interests | — | 02009 | |
| 16 June 2026, 16:14 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 15:03 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 15:01 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 14:54 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 12 June 2026, 14:45 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 29 May 2026, 17:10 | Results of Extraordinary General Meeting | Meetings & Governance | — | 08003 | |
| 19 May 2026, 09:21 | Photosoft Platform Expands to Eye Diseases Via Partnership | Company Update | MS | 11001 | |
| 11 May 2026, 16:25 | Correction to Appendix 3Y - Alistair Bennallack | Director Interests | — | 02009 | |
| 1 May 2026, 14:40 | Notification of cessation of securities - IVX | Securities Administration | — | 06027 | |
| 30 Apr 2026, 11:40 | Appendix 4C and Quarterly Activities Report - March 2026 | Quarterly Reports | MS | 19003, 19008 | |
| 28 Apr 2026, 10:54 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 | |
| 22 Apr 2026, 08:51 | Bionnova 2026 Investor Presentation | Presentations | — | 03026 | |
| 21 Apr 2026, 09:46 | Skin Cancer Trial Moves to BCC With More Encouraging Signals | Company Update | MS | 11001 | |
| 20 Apr 2026, 12:19 | Appendix 3Y Clarification | Company Administration | — | 12008 | |
| 20 Apr 2026, 12:17 | Change of Director's Interest Notice - Thian Chew | Director Interests | — | 02009 | |
| 8 Apr 2026, 11:04 | Change of Substantial Holding | Substantial Holders | — | 02002 | |
| 23 Mar 2026, 11:09 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 23 Mar 2026, 11:04 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 18 Mar 2026, 16:48 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 12 Mar 2026, 11:22 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 5 Mar 2026, 12:48 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 5 Mar 2026, 12:43 | Application for quotation of securities - IVX | Securities Administration | — | 06020 | |
| 5 Mar 2026, 09:48 | Cleansing Notice - Convertible Notes | Securities Administration | — | 06009, 06018 | |
| 5 Mar 2026, 09:39 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 27 Feb 2026, 09:32 | Appendix 4D and Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 19 Feb 2026, 09:00 | Emergence 2026 Investor Presentation | Presentations | — | 03026 | |
| 19 Feb 2026, 08:52 | Notification regarding unquoted securities - IVX | Securities Administration | — | 06021 | |
| 30 Jan 2026, 18:18 | Appendix 4C and Quarterly Activities Report - December 2025 | Quarterly Reports | MS | 19002, 19007 | |
| 30 Jan 2026, 18:15 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 30 Jan 2026, 18:14 | Proposed issue of securities - IVX | Securities Administration | — | 06013 | |
| 30 Jan 2026, 18:14 | Major Shareholders Lead Invion $1.3M Capital Raise | Securities Administration | MS | 06009, 09014 | |
| 29 Jan 2026, 10:00 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 29 Jan 2026, 09:44 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 13 Jan 2026, 11:08 | Notification of cessation of securities - IVX | Securities Administration | — | 06027 | |
| 23 Dec 2025, 09:37 | Hanlim & Korean Government Fund Pathway to Clinical Trial | Company Update | MS | 11001 | |
| 3 Dec 2025, 08:43 | Invion Secures Expanded Photosoft Global Exclusive License | Company Update | MS | 11001 |
1–50 of 74
1 / 2